Invitation to the Annual General Meeting
March 11, 2025 07:00 ET
|
Novonesis (Novozymes A/S)
The Annual General Meeting of Novonesis (Novozymes A/S) will be held on Thursday April 3, 2025 at 4:00 pm CEST at Gammel Venlighedsvej 14, DK-2970 Hoersholm, Denmark. There will also be access to the...
Transactions under Novonesis’ share buyback program
March 10, 2025 10:08 ET
|
Novonesis (Novozymes A/S)
Please read the announcement in PDF
Attachment
2025_10_Share_buyback_program
...
Trading by management and close relations of management
March 06, 2025 08:22 ET
|
Novonesis (Novozymes A/S)
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Election of employee representatives to the Board of Directors
March 05, 2025 07:52 ET
|
Novonesis (Novozymes A/S)
The employees have conducted the election of employee representatives to the Board of Directors of Novonesis (Novozymes A/S). The following employee representatives (in alphabetical order after...
Trading by management and close relations of management
March 05, 2025 03:33 ET
|
Novonesis (Novozymes A/S)
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Initiation of share buyback program
March 05, 2025 02:42 ET
|
Novonesis (Novozymes A/S)
On March 5, 2025, Novonesis will initiate a share buyback program as announced in Company Announcement No. 3 of February 26, 2025. Under the program, Novonesis will buy back B shares worth up to EUR...
Trading by management and close relations of management
March 03, 2025 06:16 ET
|
Novonesis (Novozymes A/S)
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Trading by management and close relations of management
February 27, 2025 03:39 ET
|
Novonesis (Novozymes A/S)
The Executive Leadership Team members eligible for the Novozymes A/S 2022-2024 incentive program has on February 26, 2025, received the allocated shares. An overview of the number and value of shares...
12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025
February 26, 2025 02:04 ET
|
Novonesis (Novozymes A/S)
Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of...
12M 2024 Company announcement
February 26, 2025 01:58 ET
|
Novonesis (Novozymes A/S)
2024 organic pro forma sales growth of 8%, with pro forma adjusted EBITDA margin of 36.1%. 2025 outlook of 5-8% organic pro forma sales growth and 37-38% adjusted EBITDA margin. 2024 organic pro...